Electroconvulsive therapy: A review on indications, methods, risks and medication

European Psychiatry

Volumn 11, Issue 4, 1996, Pages 165-174

  Stevens, A ^a   Fischer, A ^a   Bartels, M ^a   Buchkremer, G ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

dementia; depression; ECT; electroconvulsive therapy; mania; medication; predictive factors

Indexed keywords

ATROPINE; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; LIDOCAINE; NIFEDIPINE;

BLOOD BRAIN BARRIER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DEMENTIA; DRUG CONTRAINDICATION; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; HEART ARRHYTHMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR DEPRESSION; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MORTALITY; NEUROLOGICAL COMPLICATION; NEUROSIS; PAIN; PARKINSON DISEASE; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SEIZURE THRESHOLD; TREATMENT PLANNING;

EID: 0029773909     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-9338(96)88386-6     Document Type: Review

References (95)

1. Abrams R, Swartz CM, Vedak C. Antidepressant effects of high-dose right unilateral electroconvulsive therapy. Arch Gen Psychiatry 1991;48:746-8
2. Abrams R, Swartz CM, Vedak C. Antidepressant effects of right versus left unilateral ECT and the lateralization theory of ECT action. Am J Psychiatry 1989;146:1190-2
3. Abrams R, Taylor R. Diencephalic stimulation and the effects of ECT in endogenous depression. Br J Psychiatry 1976; 129:482-5
4. Abrams R. Clinical prediction of ECT response in depressed patients. Psychopharmacol Bull 1982;18:48-50
5. Abrams R. Electroconvulsive Therapy. 2d ed. Oxford: Oxford University Press, 1992
6. Abrams R. Electroconvulsive Therapy. Oxford: Oxford University Press, 1988;95-98
7. Andersen K, Balldin J, Gottfries C et al. A double-blind evaluation of ECT in Parkinson's disease with "on-off" phenomena. Acta Neurol Scand 1987;76:191-9
8. Bagadia VN, Abhyankar RR, Doshi J, Pradhan PV, Shah LP. A double-blind controlled study of ECT vs chlorpromazine in schizophrenia. J Assoc Physicians India 1983;31:637-40
9. Barton JL, Mehta S, Snaith RP. The prophylactic value of ECT in depressive illness. Acta Psychiatrica Scand 1973;49: 386-92
10. Black DW, Bell S, Hulbeert J. The importance of axis II in patients with major depression. J Affective Disord 1988;14: 115-22
11. Bolwig T. Blood-brain barrier studies with special reference to epileptic seizures. Acta Psychiatrica Scand Suppl 1988;345: 15-20
12. Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Easton S. Leicester ECT trial. Results in schizophrenia. Br J Psychiatry 1985;146:177-83
13. Chen JJ, Velamati S, Stewart C. Detection of prolonged seizure by audible EEG. Convulsive Ther 1990;6:248-50
14. Coffey CE, Weiner RD, Djang WT et al. Brain anatomic effects of ECT: a prospective magnetic resonance imaging study. Arch Gen Psychiatry 1991;48:1013-21
15. Coffey CE, Wilkinson WE, Weiner RD et al. Quantitative cerebral anatomy in depression: a controlled magnetic resonance imaging study. Arch Gen Psychiatry 1993;50:7-16
16. Crow TJ, Deakin JFW, Johnstone EC. The Northwick Park ECT trial. Predictors of response to real and simulated ECT. Br J Psychiatry 1984;144:227-37
17. Crow TJ, Johnstone EC. Controlled trials of electroconvulsive therapy. Ann N Y Acad Sci 1986;462:12-29
18. D'Elia G, Raotma H. Is unilateral ECT less effective than bilateral ECT? Br J Psychiatry 1975;126:83-9
19. Davis JM, Janicak PG, Sakkas P, Gilmore C, Wang Z. Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome. Convulsive Ther 1991;7:111-20
20. Devanand DP, Dwork AJ, Hutchinson ER, Bolwig TG, Sackeim HA. Does ECT alter brain structure? Am J Psychiatry 1994;151:957-70
21. Dodwell D, Goldberg D. A study of factors associated with response to electroconvulsive therapy in patients with schizophrenic symptoms. Br J Psychiatry 1989;154:635-9
22. Dressler DM, Folk J. The treatment of depression with ECT in the presence of brain tumor. Am J Psychiatry 1975;132: 1320-1
23. Fink M. Convulsive Therapy: Theory and Practice. New York: Raven Press, 1979
24. Finlay-Jones R, Parker G. A consensus conference on psychotic depression. Aust-N-Z-J-Psychiatry 1993;27:581-9
25. Flaherty JA, Naidu J, Dysken M. ECT, emergent dyskinesia, and depression. Am J Psychiatry 1984;141:808-9
26. Freese KJ. Can patients safely undergo electroconvulsive therapy while receiving monoamine oxidase inhibitors? Convulsive Ther 1985;1:190-4
27. Gangadhar BN, Janakiramajah N, Subbakrishna DK, Praveen J, Reddy AK. Twice versus thrice weekly ECT in melancholia: a double-blind prospective comparison. Anesth Analg 1992;75:511-4
28. Gangadhar BN, Kapur RL, Kalyanasundaram S. Comparison of electroconvulsive therapy with imipramine in endogenous depression: a double-blind study. Br J Psychiatry 1982;141: 367-71
29. Gilmore JH, Isley MR, Evans DL et al. The reliability of computer-processed EEG in the determination of ECT seizure duration. Convulsive Ther 1991;7:166-74
30. Greenblatt M, Grosser GH, Wechsler H. Differential response of hospitalized depressed patients in somatic therapy. Am J Psychiatry 1964;120:935-43
31. Jeanneau A. Electroconvulsive therapy in the treatment of Parkinson disease. Encephale 1993;19:573-8
32. Kellner CH, Monroe RR, Pritchett J, Jarrell MP, Bernstein HJ, Burns CM. Weekly ECT in geriatric depression. Convulsive Ther 1992;8:245-52
33. King JH, Nuss S. Reflex sympathetic dystrophy treated by electroconvulsive therapy: intractable pain, depression and bilateral electrode ECT. Pain 1993;55:393-6
34. Kolbeinsson H, Petursson H. Electroencephalographic correlates of electroconvulsive therapy. Acta Psychiatrica Scand 1988;78:162-8
35. Kramer BA Poor response to ECT in patients with a combined diagnosis of major depression and personality disorder. Lancet 1983;1:1048
36. Kramer BA. Use of ECT in California, 1977-1983. Am J Psychiatry 1985;142:1190-2
37. Krystal AD, Weiner RD, McCall WV et al. The effects of ECT stimulus dose and electrode placement on the ictal encephalogram: an intraindividual crossover study. Biol Psychiatry 1993;34:759-67
38. Lambourn J, Gill D. A controlled comparison of simulated and real ECT. Br J Psychiatry 1978;133:514-9
39. Larson G, Swartz C, Abrams R. Duration of ECT-induced tachycardia as a measure of seizure length. Am J Psychiatry 1984;141:1269-71
40. Lettemendia FJJ, Delva NJ, Rodenburg M et al. Therapeutic advantage of bifrontal electrode placement in ECT. Psychol Med 1993;23:349-60
41. Liberzon I, deQuardo JR, Sidell G, Mazzara C, Tandon R. Post-ECT dyskinesia. Convulsive Ther 1991;7:40-4
42. Liston EH, Guze BH, Baxter LR Jr, Richeimer SH, Gold ME. Motor versus EEG seizure duration in ECT. Biol Psychiatry 1988;24:94-6
43. Mander AJ, Whitfield A, Kean D, Smith MA, Douglas RH, Kendell RE. Cerebral an brain stem changes after ECT revealed by nuclear magnetic resonance imaging. Br J Psychiatry 1987;151:69-71
44. Markwort S, Bahro M, Schmitt M, Krumm B, Hewer W. EKT im höheren Lebensalter. Fortschr Neurol Psychiat 1992; 60:190
45. McCall WV, Shelp FE, Weiner RD, Austin S, Harrill A. Effects of labetalol on hemodynamics and seizure duration during ECT. Convulsive Ther 1991;7:5-14
46. McCall WV, Shelp FE, Weiner RD, Austin S, Norris J. Convulsive threshold differences in right-unilateral and bilateral ECT. Biol Psychiatry 1993;34:606-11
47. Medical Research Council. Clinical trial of the treatment of depressive illness. Br Med J 1965;5439:881-6
48. Meldrum BS. Neuropathological consequences of chemically and electrically induced seizures. Ann N Y Acad Sci 1986; 462:186-93
49. Miller LJ. Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry 1994;45:444-50
50. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years experience. Am J Psychiatry 1994;151:169-76
51. Mukherjee S. Mechanisms of antimanic effect of electroconvulsive therapy. Convulsive Ther 1989;5:227-43
52. Murray GB, Shea V, Conn DK. Electroconvulsive therapy for poststroke depression. J Clin Psychiatry 1986;47:258-60
53. Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J. EEG Manifestations during ECT: Effects of electrode placement and stimulus intensity. Biol Psychiatry 1993;34:321-30
54. Ottoson JO. Experimental studies of the mode of action of electroconvulsive therapy. Acta Psychiatrica et Neurologica Scandinavica Suppl 1960;145:1-141
55. Penney JF, Dinwiddie SH, Zorumski CF, Wetzel RD. Concurrent and close temporal administration of lithium and ECT. Convulsive Ther 1990;6:139-45
56. Perry SW. HIV-related depression. Res Publ Assoc Res Nerv Ment Dis 1994;72:223-36
57. Petrides G, Dhossche D, Fink M, Francis A. Continuation ECT: Relapse prevention in affective disorders. Convuls Ther 1994;10:189-94
58. Post RM, Uhde TW, Rubinow DR. Differential time course for antidepressant effects after sleep deprivation, ECT and carbamazepine: clinical and theoretical implications. Psychiatry Res 1987;22:11-9
59. Price RF, Mackenzie TB, Ticker GJ, Culver C. The dose-response ratio in ECT. Arch Gen Psychiatry 1978;35: 1131-6
60. Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 1990;31:287-96
61. Richard CL, Black NA. The efficacy of ECT: II. Correlation of specific treatment variables to response rate in unilateral ECT. Psychiatry Res 1985;16:147-54
62. Rifkin A. ECT versus tricyclic antidepressants in depression: a review of the evidence. J Clin Psychiatry 1988;49:3-7
63. Rodger CR, Scott AI, Whalley LJ. Is there a delay of the antidepressant effect of electroconvulsive therapy? Br J Psychiatry 1994;164:106-9
64. Sackeim HA, Decina P, Kanzler M, Kerr B, Malitz S. Effects of electrode placement on the efficacy of titrated, low dosage ECT. Am J Psychiatry 1987;144:1449-55
65. Sackeim HA, Decina P, Portnoy S, Neeley P, Malitz S. Studies of dosage, seizure threshold and seizure duration in ECT. Biol Psychiatry 1987;22:249-68
66. Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold and seizure duration: Impact on the efficacy and safety of electroconvulsive therapy. Psychiatry Clin N America 1991;14:803-43
67. Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990;10:96-104
68. Sackeim HA, Prudic J, Devanand DP et al. Effects of stimulus intensity and electrode placements on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 1993;328:839-46
69. Sackeim HA. Use of ECT in late-life depression. In: Schneider LS, Reynolds CF III, Lebowitz BD, Friedhoff AJ, eds. Diagnosis and Treatments of depression in Late-Life. Washington DC: American Psychiatric Press, 1994; 259-77
70. Scott AI, Turnbull LW. Do repeated courses of ECT cause brain damage detectable by MRI? Am J Psychiatry 1990;147: 371-2
71. Scott AI, Douglas RH, Whitfield A, Kendell RE. Time course of cerebral magnetic resonance changes after electroconvulsive therapy. Br J Psychiatry 1990;156:551-3
72. Shapira B, Valev A, Lerer B. Twice vs three times weekly ECT: Results of the Jerusalem double-blind study 1: Clinical Outcome measures (abstract). Convulsive Ther 1992;8:77
73. Skoog I. The prevalence of psychotic, depressive and anxiety syndromes in demented and non-demented elderly. J Geriatr Psychiatry 1993;8:247-53
74. Stein G. Drug treatment of the personality disorders. Br J Psychiatry 1992;161:167-74
75. Stoudemire A, Hill CD, Morris R, Martino-Salzman D, Lewison B. Long term affective and cognitive outcome in depressed older adults. Am J Psychiatry 1993;150: 896-900
76. Stoudemire A, Knos G, Gladson M, Markwalter H, Sung YF, Morris R, Cooper R. Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients. J Clin Psychiatry 1990;51: 508-12
77. Swartz CM, Larson G. ECT stimulus duration and it's efficacy. Ann Clin Psychiatry 1989;1:147-52
78. Taylor P, Fleminger JJ. ECT for schizophrenia. Lancet 1980;1: 1380-2
79. Taylor PJ, von Witt RJ, Fry AH. Serum creatine phosphokinase activity in psychiatric patients receiving ECT. J Clin Psychiatry 1981;42:103-5
80. Teri L, Wagner A. Alzheimer's disease and depression. J Consult Clin Psychol 1992;60:379-91
81. Tyrer P, Casey P, Gall J. Relationship between neurosis and personality disorder. Br J Psychiatry 1983;142:404-8
82. Vanelle JM, Loo H, Galinowski A et al. Maintenance ECT in intractable manic-depressive disorders. Convuls Ther 1994; 10:195-205
83. Volavka J, Feldstein S, Abrams R, Fink M. EEG and clinical change after bilateral and unilateral electroconvulsive therapy. Electroencephalogr Clin Neurophysiol 1972;32:631-9
84. Webb MC, Coffey CE, Saunders WR et al. Cardiovascular response to unilateral electroconvulsive therapy. Biol Psychiatry 1990;28:758-66
85. Weiner RD, Rogers HJ, Squire LR. Effects of stimulus parameters on cognitive side effects. Ann N Y Acad Sci 1986;462: 315-25
86. Weiner RD. Does electroconvulsive therapy cause brain damage? Behav Brain Sci 1984;7:1-53
87. Weinger MB, Partridge BL, Hauger R, Mirow A. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics. Anesth Analgesia 1991;73:556-62
88. Welch CA, Drop LJ. Cardiovascular effects of ECT. Convulsive Ther 1989;5:35-43
89. Wells DG, Davies GG, Rosewarne F. Attenuation of electroconvulsive therapy induced hypertension with sublingual nifedipine. Anesthesia Intensive Care 1989;17:31-3
90. Wilkinson AM, Anderson DN, Peter S. Age and the effects of ECT. Int Geriatr Psychiatry 1993;8:401-6
91. Zervas IM, Calev A, Jandorv L et al. Age dependent effects of electroconvulsive therapy on memory. Convulsive Ther 1993;9:39-42
92. Zielinsky RJ, Rose SP, Devanand DP, Woodring S, Sackeim HA, Cardiovascular Complications of ECT in depressed patients with cardiac disease. Am J Psychiatry 1993;150: 904-9
93. Zimmermann M, Coryell W, Pfohl B, Corenthal C, Stangl D. ECT response in depressed patients with and without a DSM-III-R personality disorder. Am J Psychiatry 1986;143: 1030-2
94. Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 1993;13:397-408
95. Zwil AS, McAllister TW, Price TR. Safety and efficacy of ECT in depressed patients with organic brain disease: review of a clinical experience. Convulsive Ther 1992;8:204-10